enGene Names Amy Pott as Chief Global Commercialization Officer
May 29, 2025
enGene Holdings, a clinical-stage, non-viral genetic medicines company, announced the appointment of Amy Pott as Chief Global Commercialization Officer. In this role, Ms. Pott will